Stay updated on Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Sign up to get notified when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.

Latest updates to the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page
- Check7 days agoChange DetectedThe page now includes a status metadata block with the last known status, the contributing organization (International AIDS Vaccine Initiative), and the verification date (2024-04). This addition adds context about who verified the status and when.SummaryDifference0.4%

- Check14 days agoChange DetectedThe page revision tag was updated from Revision: v3.5.2 to Revision: v3.5.3, indicating a newer version of the page. This update does not change any study content or user-facing details.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page’s release/version label was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check43 days agoChange DetectedTexas location listing updated from UT Health San Antonio to The University of Texas Health Science Center at San Antonio.SummaryDifference0.1%

- Check50 days agoChange Detected- Revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed on the page.SummaryDifference0.1%

Stay in the know with updates to Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.